2 completed, 1 terminated. 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Thomas M. Lietman: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Steroids and Cross-linking for Ulcer Treatment Moxifloxacin Ophthalmic, Difluprednate Ophthalmic, Riboflavin Ophthalmic - Keratitis Bacterial | Phase 3 | Completed | Thomas M. Lietman | 280 | 2020-09-24 | 2025-02-03 |
| Azithromycin for COVID-19 Treatment in Outpatients Nationwide Azithromycin, Placebos - COVID-19, SARS-CoV-2 | Phase 3 | Terminated | Thomas M. Lietman | 263 | 2020-05-22 | 2023-03-02 |
| Steroids for Corneal Ulcers Trial Antibiotics, Topical corticosteroid, Placebo - Corneal Ulcer, Eye Infections, Bacterial | Phase 4 | Completed | Thomas M. Lietman | 500 | 2006-09-01 | 2018-08-01 |
Bacterial Infections (1) · COVID-19 (1) · Corneal Ulcer (1) · Eye Diseases (1) · Eye Infections, Bacterial (1)
Adrenal Cortex Hormones (1) · Anti-Bacterial Agents (1) · Azithromycin (1) · Corneal Cross-Linking (1) · Moxifloxacin (1)
United States (3) · India (2)
Catherine Oldenburg, ScD, MPH (1) · Jennifer Rose-Nussbaumer, MD (1) · M. Srinivasan, M.S., O.D. (1) · Mike Zegans, M.D. (1) · Nicole Varnado, MPH (1) · Nisha Acharya, M.D., M.S. (1) · Thomas M Lietman, M.D. (1) · Thuy Doan, MD, PhD (1) · Tom Lietman, MD (1)
PMID 18829631, PMID 21987582, PMID 22159005, PMID 22395880, PMID 22447793, PMID 22959881, PMID 23307105, PMID 23385795, PMID 24315294, PMID 24612976, PMID 24618327, PMID 27631025, PMID 34269813, PMID 34901464, PMID 38112645, PMID 40705354
U10EY015114 (1), UG1EY028518 (1)